查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813205

脑脊髓液 (CSF) 管理设备的全球市场:产品·年龄层·终端用户·各地区 (～2027年)

Global Cerebrospinal Fluid Management Devices Market Research Report Information by Product, by Age Group, by End User, and by Region Forecast till 2027
出版日期: | 出版商: Market Research Future | 英文 142 Pages | 订单完成后即时交付

价格

产业概要

预计到 2027 年，全球脑脊髓液 (CSF) 管理设备市场规模将达到 38.2161 亿美元，预测期内复合年增长率为 5.45%。

脑脊髓液管理设备有助于维持中枢神经系统的脑脊髓液平衡。透过引流或分流多余的脑脊髓液，它们可以降低颅内压，并在治疗脑积水和创伤性脑损伤等疾病方面发挥重要作用。

全球老龄人口的成长是推动该市场成长的主要因素之一。此年龄层常见的与年龄相关的神经系统疾病包括阿兹海默症、帕金森氏症和中风。联合国预测，到2050年，老年人口将达到4.25亿，这将进一步增加医疗保健需求。这些人口结构变化可能会对脑脊髓液管理设备的需求产生最大影响。老年患者通常患有退化性疾病和合併症，这增加了对临床干预的需求。

区域分析

美洲市场在数量上领先全球，这得益于参与公司的大量资本投资、优质的医院基础设施以及众多的研发项目。 2019年，北美市场销售额为7.0599亿美元，拉丁美洲市场销售额为2.1313亿美元。

欧洲市场竞争依然激烈，其中西欧占最大占有率。为了维持市场地位，各公司正专注于与医生建立关係并实施针对特定产品的培训计划，这推动了设备采用率的提高。欧洲市场也表现强劲，西欧市场销售额为5.4303亿美元，东欧市场销售额为1.548亿美元。

亚太地区正成为一个充满活力的市场，由于医疗保健支出的快速增长以及政府对研发的大力支持，其成长潜力巨大。该地区的学术会议和研讨会是知识共享的催化剂。中国以1.9098亿美元的市场规模领先，其次是日本（1.2510亿美元）和印度（9,868万美元）。

本报告探讨了全球脑脊髓液 (CSF) 管理设备市场，包括市场定义和概述、影响市场成长的各种因素分析、市场规模趋势和预测、按不同细分市场、地区和主要国家/地区进行的细分、竞争格局以及主要公司的概况。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

  • 概要
  • 促进因素
    • 脑积水盛行率上升及分流手术数量增加
    • 老化人口增加
  • 阻碍因素
    • 脑脊髓液分流系统相关併发症
  • 机遇
    • 进入新兴市场
  • 新冠疫情影响分析

第5章 市场要素分析

  • 价值链分析
  • 波特的五力分析

第6章 全球脑脊髓液 (CSF) 管理设备市场:各产品

  • 概要
  • 分流术
  • 重症加护产品
  • 硬薄膜密封胶
  • 其他

第7章 全球脑脊髓液 (CSF) 管理设备市场:各年龄层

  • 概要
  • 儿童
  • 成人
  • 老年人

第8章 全球脑脊髓液 (CSF) 管理设备市场:各终端用户

  • 概要
  • 医院
  • 门诊病人诊疗
  • 研究·学术机构

第9章 全球脑脊髓液 (CSF) 管理设备市场:各地区

  • 概要
  • 南北美洲
    • 北美
    • 南美
  • 欧洲
    • 西欧
    • 东欧
  • 亚太地区
    • 中国
    • 日本
    • 其他
    • 印度
    • 韩国
    • 澳洲
  • 中东·非洲
    • 中东
    • 非洲

第10章 竞争情形

  • 概要
  • 竞争基准
  • 主要成长策略
  • 开发数量居首的企业
  • 主要的开发分析
  • 主要的展开·成长策略
  • 财务矩阵

第11章 企业简介

  • MEDTRONIC PLC
  • NATUS MEDICAL INCORPORATED
  • B. BRAUN MELSUNGEN AG
  • SOPHYSA
  • IRRAS AB
  • MOLLER MEDICAL GMBH
  • ARGI GRUP
  • LONGEVITI
  • INTEGRA LIFESCIENCES CORPORATION
  • ANUNCIA

第12章 附录

Product Code: MRFR/HC/5730-CR

Global Cerebrospinal Fluid Management Devices Market Research Report Information by Product (Shunts, Valve, Critical Care Products, Dural Sealants, Others), by Age Group (Pediatric, Adult, Geriatric), by End User (Hospitals, Ambulatory Settings, Research and Academic Institutes, Others), and by Region (Americas, Europe, Asia-Pacific, Middle East & Africa) Forecast till 2027

Industry Overview

The global cerebrospinal fluid management devices market is expected to achieve a value of USD 3,821.61 million by 2027, expanding at a 5.45% CAGR by the end of 2027. Cerebrospinal fluid management devices help maintain the balance of CSF within the central nervous system. By draining or diverting excess fluid, these devices reduce intracranial pressure and are vital for treating conditions like hydrocephalus and traumatic brain injury.

The increase in the elderly population globally is among the main factors that have contributed to the growth of the cerebrospinal fluid management devices market. The age-related neurological disorders that are also generally healthy in this group of people include Alzheimer's disease, Parkinson's, and stroke. The United Nations predicts that the number of elderly will rise to 425 million by 2050, which will mean higher healthcare needs. Such an evolution of the demographic structure is expected to have the most profound effect on the demand for CSF management devices, as the elderly in general are the least healthy with degenerative diseases and complications requiring clinical intervention.

Major Company Development

In October 2017, Natus Medical Incorporated took over the neurosurgical product line of Integra LifeSciences to supplement its product offerings. The deal amounted to the acquisition of the Camino ICP monitoring line, US rights to fixed pressure shunts, CSF collection systems, Codman's DURAFORM dural graft implant, and standard EVD catheters, among others. Through the union of these products, Natus widened its knowledge base in neurological care and strengthened its competitive position. The strategic move was aimed at accelerating growth and strengthening the company's presence in the global cerebrospinal fluid management devices market.

Key Players

Major players in the global cerebrospinal fluid management devices market are Medtronic PLC, Natus Medical Incorporated, B. Braun Melsungen AG, Sophysa, IRRAS AB, Moller Medical GmbH, Argi Grup, Longeviti, Integra LifeSciences, Corporation, and Anuncia.

Report Attribute Details

  • Market Size 2019: USD 2,505.13 Million
  • Market Size 2027: USD 3,821.61Million
  • CAGR (2020-2027): 5.45%
  • Base Year: 2019
  • Market Forecast Period: 2020-2027

Industry Segmentations

  • By Product: Shunts - 5.26%, Critical Care Products - 5.44%.
  • By Age Group: Pediatric - 5.30%, Adult - 5.67%.
  • By End User: Hospitals - 5.41%, Ambulatory Settings - 5.71%.

Regional Analysis

The CSF management devices market in the Americas leads in volume, which is supported by the presence of industry players with huge capital investments, good hospital infrastructure, and a significant number of R&D projects. In 2019, North America generated USD 705.99 million, complemented by USD 213.13 million from Latin America.

Europe is still a competitive market that drives innovation, and it is mainly the Western part of Europe that has the largest share. To keep their position, companies concentrate on staff-surgeon relations and product-specific training programs, which creates higher usage of implantable devices for CSF management. Europe posted notable figures, with Western Europe contributing USD 543.03 million and Eastern Europe adding USD 154.80 million.

The Asia-Pacific area is becoming a highly dynamic market and is likely to be a region of high potential with soaring healthcare spending and a strong government support for R&D. The organizations and conferences in the region act as the brakes on the machine of knowledge exchange. China led at USD 190.98 million, while Japan and India followed with USD 125.10 million and USD 98.68 million.

The Middle East & Africa market is still in its developmental stage, yet it holds long-term promise with increasing hospital expansions and growing collaborations. GCC nations are actively investing in healthcare modernization, encouraging partnerships with multinational companies.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW
  • 1.2 MARKET SYNOPSIS

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY
  • 2.2 RESEARCH OBJECTIVE
  • 2.3 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA MINING
  • 3.3 SECONDARY RESEARCH
  • 3.4 PRIMARY RESEARCH
    • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
    • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PREVALENCE OF HYDROCEPHALUS & SUBSEQUENT RISE IN NUMBER OF SHUNTING PROCEDURES
    • 4.2.2 GROWING GERIATRIC POPULATION
  • 4.3 RESTRAINT
    • 4.3.1 COMPLICATIONS RELATED TO CSF SHUNT SYSTEMS
  • 4.4 OPPORTUNITY
    • 4.4.1 ENTERING DEVELOPING MARKETS
  • 4.5 COVID-19 IMPACT ANALYSIS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D AND DESIGNING
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION
    • 5.1.4 MARKETING AND SALES
    • 5.1.5 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 BARGAINING POWER OF BUYERS
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 INTENSITY OF RIVALRY

6 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 SHUNTS
  • 6.3 CRITICAL CARE PRODUCTS
  • 6.4 DURAL SEALANTS
  • 6.5 OTHERS

7 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP

  • 7.1 OVERVIEW
  • 7.2 PEDIATRIC
  • 7.3 ADULT
  • 7.4 GERIATRIC

8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
  • 8.3 AMBULATORY SETTINGS
  • 8.4 RESEARCH & ACADEMIC INSTITUTES

9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 AMERICAS
    • 9.2.1 NORTH AMERICA
      • 9.2.1.1 US
      • 9.2.1.2 CANADA
    • 9.2.2 LATIN AMERICA
  • 9.3 EUROPE
    • 9.3.1 WESTERN EUROPE
      • 9.3.1.1 GERMANY
      • 9.3.1.2 FRANCE
      • 9.3.1.3 REST OF WESTERN EUROPE
      • 9.3.1.4 UK
      • 9.3.1.5 ITALY
      • 9.3.1.6 SPAIN
    • 9.3.2 EASTERN EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 REST OF ASIA PACIFIC
    • 9.4.4 INDIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 AUSTRALIA
  • 9.5 MIDDLE EAST & AFRICA
    • 9.5.1 MIDDLE EAST
    • 9.5.2 AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING
  • 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
  • 10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
  • 10.5 KEY DEVELOPMENT ANALYSIS
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.6.1 ACQUISITION ACTIVITIES
    • 10.6.2 EXPANSIONS
    • 10.6.3 PRODUCT LAUNCHES
  • 10.7 FINANCIAL MATRIX
    • 10.7.1 SALES
    • 10.7.2 R&D EXPENDITURE

11 COMPANY PROFILES

  • 11.1 MEDTRONIC PLC
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS/SERVICES OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 NATUS MEDICAL INCORPORATED
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS/SERVICES OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 B. BRAUN MELSUNGEN AG
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS/SERVICES OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 SOPHYSA
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS/SERVICES OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 IRRAS AB
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS/SERVICES OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 MOLLER MEDICAL GMBH
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS/SERVICES OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS
    • 11.6.6 KEY STRATEGIES
  • 11.7 ARGI GRUP
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS/SERVICES OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 LONGEVITI
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS/SERVICES OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 INTEGRA LIFESCIENCES CORPORATION
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS/SERVICES OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 ANUNCIA
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS/SERVICES OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 SWOT ANALYSIS
    • 11.10.6 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS
  • TABLE 2 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2017-2027 (USD MILLION)
  • TABLE 3 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS, BY REGION 2017-2027 (USD MILLION)
  • TABLE 4 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 5 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 6 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCTS, BY REGION 2017-2027 (USD MILLION)
  • TABLE 7 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCTS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR DURAL SEALANTS, BY REGION 2017-2027 (USD MILLION)
  • TABLE 10 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2017-2027 (USD MILLION)
  • TABLE 11 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR PEDIATRIC, BY REGION 2017-2027 (USD MILLION)
  • TABLE 12 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR ADULT, BY REGION 2017-2027 (USD MILLION)
  • TABLE 13 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR GERIATRIC, BY REGION 2017-2027 (USD MILLION)
  • TABLE 14 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2017-2027 (USD MILLION)
  • TABLE 15 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR HOSPITALS, BY REGION 2017-2027 (USD MILLION)
  • TABLE 16 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR AMBULATORY SETTINGS, BY REGION 2017-2027 (USD MILLION)
  • TABLE 17 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION 2017-2027 (USD MILLION)
  • TABLE 18 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION, 2019 (%)
  • TABLE 19 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2017-2027 (USD MILLION)
  • TABLE 20 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 21 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 22 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 23 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 24 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 25 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 26 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 27 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 28 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
  • TABLE 29 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 30 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 31 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 32 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 33 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 34 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 35 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 36 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 37 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 38 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 39 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 40 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 41 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 42 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 43 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 44 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 45 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 46 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 47 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 48 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 49 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 50 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 51 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 52 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 53 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 54 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 55 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 56 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 57 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 58 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 59 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 60 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 61 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 62 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 63 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 64 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 65 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY 2017-2027 (USD MILLION)
  • TABLE 66 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 67 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 68 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 69 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 70 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 71 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 72 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 73 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 74 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 75 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 76 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 77 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 78 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 79 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 80 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 81 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 82 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 83 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 84 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 85 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 86 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 87 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 88 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 89 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 90 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 91 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 92 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 93 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 94 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 95 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 96 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 97 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 98 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 99 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 100 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 101 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 102 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 103 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 104 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 105 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 106 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 107 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 108 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 109 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 110 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 111 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 112 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 113 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 114 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 115 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 116 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 117 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 118 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 119 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 120 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 121 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 122 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
  • TABLE 123 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 124 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 125 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 126 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 127 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 128 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 129 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 130 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 131 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 132 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 133 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 134 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 135 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 136 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 137 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 138 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 139 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 140 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 141 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 142 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 143 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 144 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 145 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 146 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 147 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 148 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 149 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 150 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 151 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 152 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 153 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 154 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 155 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 156 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 157 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 158 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 159 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 160 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 161 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 162 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 163 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 164 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 165 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 166 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 167 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 168 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 169 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 170 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 171 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 172 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 173 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 174 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 178 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 180 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 181 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 182 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 183 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 184 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 185 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 186 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 187 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
  • TABLE 188 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 189 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 190 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 191 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
  • TABLE 192 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
  • TABLE 193 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 194 BENCHMARKING OF MAJOR COMPETITORS
  • TABLE 195 ACTIVE PLAYERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
  • TABLE 196 ACQUISITION ACTIVITIES
  • TABLE 197 EXPANSIONS
  • TABLE 198 PRODUCT LAUNCHES
  • TABLE 199 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED
  • TABLE 200 NATUS MEDICAL INCORPORATED: PRODUCTS/SERVICES OFFERED
  • TABLE 201 NATUS MEDICAL INCORPORATED: KEY DEVELOPMENTS
  • TABLE 202 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED
  • TABLE 203 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS
  • TABLE 204 SOPHYSA: PRODUCTS/SERVICES OFFERED
  • TABLE 205 IRRAS AB: PRODUCTS/SERVICES OFFERED
  • TABLE 206 IRRAS AB: KEY DEVELOPMENTS
  • TABLE 207 MOLLER MEDICAL GMBH: PRODUCTS/SERVICES OFFERED
  • TABLE 208 ARGI GRUP: PRODUCTS/SERVICES OFFERED
  • TABLE 209 LONGEVITI: PRODUCTS/SERVICES OFFERED
  • TABLE 210 LONGEVITI: KEY DEVELOPMENTS
  • TABLE 211 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 212 INTEGRA LIFESCIENCES CORPORATION: KEY DEVELOPMENTS
  • TABLE 213 ANUNCIA: PRODUCTS/SERVICES OFFERED
  • TABLE 214 ANUNCIA: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET STRUCTURE
  • FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
  • FIGURE 4 DRIVER IMPACT ANALYSIS
  • FIGURE 5 RESTRAINT IMPACT ANALYSIS
  • FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
  • FIGURE 8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2019 (%)
  • FIGURE 9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2019 & 2027 (USD MILLION)
  • FIGURE 10 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2019 (%)
  • FIGURE 11 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2019 & 2027 (USD MILLION)
  • FIGURE 12 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2019 (%)
  • FIGURE 13 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2019 & 2027 (USD MILLION)
  • FIGURE 14 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 & 2027 (USD MILLION)
  • FIGURE 15 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%)
  • FIGURE 16 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY COUNTRY 2019 (%)
  • FIGURE 17 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%)
  • FIGURE 18 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY COUNTRY 2019 (%)
  • FIGURE 19 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%)
  • FIGURE 20 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%)
  • FIGURE 21 MAJOR MANUFACTURERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, MARKET SHARE (2019)
  • FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
  • FIGURE 23 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, COMPETITIVE LANDSCAPE
  • FIGURE 24 SALES
  • FIGURE 25 R&D EXPENDITURE
  • FIGURE 26 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 27 MEDTRONIC PLC: SWOT ANALYSIS
  • FIGURE 28 NATUS MEDICAL INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 NATUS MEDICAL INCORPORATED: SWOT ANALYSIS
  • FIGURE 30 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW
  • FIGURE 31 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
  • FIGURE 32 SOPHYSA: SWOT ANALYSIS
  • FIGURE 33 IRRAS AB: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 IRRAS AB: SWOT ANALYSIS
  • FIGURE 35 MOLLER MEDICAL GMBH: SWOT ANALYSIS
  • FIGURE 36 ARGI GRUP: SWOT ANALYSIS
  • FIGURE 37 LONGEVITI: SWOT ANALYSIS
  • FIGURE 38 INTEGRA LIFESCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 INTEGRA LIFESCIENCES CORPORATION: SWOT ANALYSIS
  • FIGURE 40 ANUNCIA: SWOT ANALYSIS